Consistent with its expression profile, knockdown of MTHFD2 decreases proliferation of tumor-derived cell lines independent of tissue of origin and prolongs survival in human xenograft and mouse acute myeloid leukemia (AML) models15,19. Here, MTHFD2 is linked to acute myeloid leukemia.